logo

Five Prime Therapeutics (FPRX)



Trade FPRX now with
  Date
  Headline
1/25/2018 8:05:51 AM Five Prime Announces Pricing Of Upsized Public Offering Of Common Stock
1/23/2018 4:03:24 PM Five Prime Announces Proposed Public Offering Of Common Stock
1/8/2018 8:33:51 AM Five Prime Earns IND Milestone Payment Under Immune Checkpoint Pathways Discovery Collaboration With Bristol-Myers
5/6/2016 6:36:21 AM Jefferies Is Lowering Five Prime Therapeutics (FPRX) 2018 Rev. Estimate To 17.1 M From 64.0 M
5/6/2016 6:36:05 AM Jefferies Is Lowering Five Prime Therapeutics (FPRX) 2017 Rev. Estimate To 17.3 M From 34.0 M
5/6/2016 6:35:52 AM Jefferies Is Cutting Five Prime Therapeutics (FPRX) 2016 Rev. Estimate To 21.3 M From 40.5 M
5/6/2016 6:35:07 AM Jefferies Is Cutting Five Prime Therapeutics (FPRX) 2018 Estimate To -4.45 From -1.97
5/6/2016 6:34:52 AM Jefferies Is Lowering Five Prime Therapeutics (FPRX) 2017 Estimate To -4.01 From -2.15
5/6/2016 6:34:35 AM Jefferies Is Lowering Five Prime Therapeutics (FPRX) 2016 Estimate To -2.39 From -1.46
5/6/2016 6:34:17 AM Jefferies Is Lowering Five Prime Therapeutics (FPRX) Q4 16 Estimate To -0.69 From -0.39
5/6/2016 6:34:00 AM Jefferies Is Lowering Five Prime Therapeutics (FPRX) Q3 16 Estimate To -0.64 From -0.37
5/6/2016 6:33:44 AM Jefferies Is Lowering Five Prime Therapeutics (FPRX) Q2 16 Estimate To -0.57 From -0.36
3/11/2016 6:15:19 AM Jefferies Is Cutting Five Prime Therapeutics (FPRX) 2018 Estimate To -1.97 From -1.85
3/11/2016 6:15:02 AM Jefferies Is Increasing Five Prime Therapeutics (FPRX) 2017 Estimate To -2.15 From -2.61
3/11/2016 6:14:46 AM Jefferies Is Raising Five Prime Therapeutics (FPRX) 2016 Estimate To -1.46 From -2.07